These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14687065)

  • 1. Factor V Leiden in pregnancies complicated by placental abruption.
    Facchinetti F
    BJOG; 2004 Jan; 111(1):93; author reply 93-4. PubMed ID: 14687065
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.
    Agorastos T; Karavida A; Lambropoulos A; Constantinidis T; Tzitzimikas S; Chrisafi S; Saravelos H; Vavilis D; Kotsis A; Bontis J
    J Matern Fetal Neonatal Med; 2002 Oct; 12(4):267-73. PubMed ID: 12572596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden in pregnancies complicated by placental abruption.
    Procházka M; Happach C; Marsál K; Dahlbäck B; Lindqvist PG
    BJOG; 2003 May; 110(5):462-6. PubMed ID: 12742330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption.
    Anteby EY; Musalam B; Milwidsky A; Blumenfeld A; Gilis S; Valsky D; Hamani Y
    Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):31-5. PubMed ID: 15036707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
    Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis.
    Dudding TE; Attia J
    Thromb Haemost; 2004 Apr; 91(4):700-11. PubMed ID: 15045131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
    Camilleri RS; Peebles D; Portmann C; Everington T; Cohen H
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):139-47. PubMed ID: 15091001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae.
    Wiener-Megnagi Z; Ben-Shlomo I; Goldberg Y; Shalev E
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1565-7. PubMed ID: 9855597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of selected thrombophilias in women with placental abruption.
    Procházka M; Lubuský M; Slavík L; Hrachovec P; Zielina P; Kudela M; Lindqvist PG
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):297-301. PubMed ID: 17627684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inheritance and perinatal consequences of inherited thrombophilia in Greece.
    Karakantza M; Androutsopoulos G; Mougiou A; Sakellaropoulos G; Kourounis G; Decavalas G
    Int J Gynaecol Obstet; 2008 Feb; 100(2):124-9. PubMed ID: 17963764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in various coagulation genes in black South African women with placental abruption.
    Hira B; Pegoraro RJ; Rom L; Govender T; Moodley J
    BJOG; 2002 May; 109(5):574-5. PubMed ID: 12066950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sucessful pregnancy outcome following three severe placental abruptions and intrauterine fetal death in the patient--heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Dimitrova V; Koleva R; Savov A; Chernev T; Khranov Iu; Georgiev G; Slŭncheva B; Raĭcheva S
    Akush Ginekol (Sofiia); 2004; 43(5):47-54. PubMed ID: 15518286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of thrombophilic defects and non-O blood group as risk factors for gestational vascular complications among Tunisian women.
    Klai S; Fekih-Mrissa N; Rachdi R; Gritli N
    Acta Haematol; 2011; 125(3):115-20. PubMed ID: 21109732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the relationship of Factor V Leiden and intrauterine growth restriction--based on solid evidence?
    Lindqvist PG; Merlo J
    Thromb Haemost; 2005 Jul; 94(1):230-1; author reply 231-2. PubMed ID: 16116698
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombophilias in pregnancy.
    Battinelli EM; Bauer KA
    Hematol Oncol Clin North Am; 2011 Apr; 25(2):323-33, viii. PubMed ID: 21444033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome.
    Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ
    Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of genetic thrombophilia in women with complications of pregnancy.
    Kupferminc MJ; Eldor A; Steinman N; Many A; Bar-Am A; Jaffa A; Fait G; Lessing JB
    N Engl J Med; 1999 Jan; 340(1):9-13. PubMed ID: 9878639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population.
    Said JM; Higgins JR; Moses EK; Walker SP; Monagle PT; Brennecke SP
    Acta Obstet Gynecol Scand; 2012 Feb; 91(2):250-5. PubMed ID: 21985600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M385T polymorphism in the factor V gene, but not Leiden mutation, is associated with placental abruption in Finnish women.
    Jääskeläinen E; Toivonen S; Romppanen EL; Helisalmi S; Keski-Nisula L; Punnonen K; Heinonen S
    Placenta; 2004; 25(8-9):730-4. PubMed ID: 15450391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden mutation and its impact on pregnancy complications.
    Hammerová L; Chabada J; Drobný J; Bátorová A
    Acta Medica (Hradec Kralove); 2011; 54(3):117-21. PubMed ID: 22250481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.